Source: European Medicines Agency (EU) Revision Year: 2021 Publisher: Pfizer Europe MA EEIG, Boulevard de la Plaine, 17 1050, Bruxelles, Belgium
Zoledronic Acid Hospira 4 mg/100 ml solution for infusion.
| Pharmaceutical Form |
|---|
|
Solution for infusion. Clear and colourless solution. |
One bag with 100 ml contains 4 mg zoledronic acid (as monohydrate).
One ml of the solution contains 0.04 mg zoledronic acid (as monohydrate).
Excipient with known effect: Zoledronic Acid Hospira 4 mg/100 ml contains 360 mg sodium per dosage unit.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Zoledronic acid |
Zoledronic acid belongs to the class of bisphosphonates and acts primarily on bone. It is an inhibitor of osteoclastic bone resorption. |
| List of Excipients |
|---|
|
Mannitol |
100 ml polypropylene bags with a polypropylene twist-off port fitted with a cap, with a polyester/polypropylene overwrap.
Pack size: Zoledronic Acid Hospira is supplied as packs containing 1 bag.
Pfizer Europe MA EEIG, Boulevard de la Plaine, 17 1050, Bruxelles, Belgium
EU/1/12/800/003
Date of first authorisation: 19 November 2012
Date of latest renewal: 24 August 2017
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
